Drugs for Side-Effects Management (Supportive Care)

Table. Drugs Prescribed for Side‑Effects Management (Supportive Care)

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Aranesp (darbepoetin alfa) Injection
Drug company
• Amgen
Indication
• Treatment of anemia associated with myelosuppressive chemotherapy
Patient support services
• Amgen Safety Net Foundation
  866-264-2778

Drug name (generic name)
• Injectafer (ferric carboxymaltose) Injection
Drug company
• Daiichi-Sankyo
Indication
• Treatment of anemia in patients with cancer
Patient support services
• Injectafer Savings Program
  866-437-4669
  
  Injectafer Patient Assistance Program

Drug name (generic name)
• Retacrit (epoetin alfa-epbx)
Drug company
• Pfizer
Indication
• Treatment of anemia associated with myelosuppressive chemotherapy
Patient support services
• Pfizer Patient Assistance Program
  877-744-5675
  
  Pfizer Oncology Together Co-Pay Savings Program
  877-744-5675

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Prolia (denosumab) Injection
Drug company
• Amgen
Indication
• To increase bone mass in high-risk men receiving androgen-deprivation therapy for non-metastatic prostate cancer, and in women receiving adjuvant aromatase inhibitor therapy for breast cancer
Patient support services
• Amgen FIRST STEP Co-Pay Program
  866-264-2778
  
  Amgen Safety Net Foundation
  866-264-2778

Drug name (generic name)
• Xgeva (denosumab) Injection
Drug company
• Amgen
Indication
• Treatment of bone metastases
Patient support services
• Amgen FIRST STEP Co-Pay Program
  866-264-2778
  
  Amgen Safety Net Foundation
  866-264-2778

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Lazanda (fentanyl) Nasal Spray
Drug company
• West Therapeutic Development
Indication
• Treatment of breakthrough cancer pain
Patient support services
• Lazanda Savings Card
  844-309-3835

Drug name (generic name)
• Subsys (fentanyl) Sublingual Spray
Drug company
• West Therapeutic Development
Indication
• Treatment of breakthrough cancer pain
Patient support services
• Subsys Cares Savings Program
  844-309-3835

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Akynzeo (netupitant & palonosetron)
Drug company
• Helsinn
Indication
• Prevention of chemotherapy-induced nausea and vomiting, in combination with dexamethasone
Patient support services
• Akynzeo Capsule Savings Card
  844-357-4668
  
  Helsinn Cares Patient Assistance Program
  844-357-4668

Drug name (generic name)
• Emend (aprepitant)
Drug company
• Merck
Indication
• Treatment of chemotherapy-induced nausea and vomiting
  
  Treatment of postoperative nausea and vomiting
Patient support services
• Merck Patient Assistance Program
  800-727-5400

Drug name (generic name)
• Sancuso (granisetron transdermal system)
Drug company
• Kyowa Kirin
Indication
• To prevent chemotherapy-induced nausea and vomiting
Patient support services
• Sancuso Copay Assistance Card Program
  877-251-4951
  
  Sancuso Patient Assistance Program
  866-325-8231
  
  Sancuso Reimbursement Assistance Program

Drug name (generic name)
• Sustol (granisetron) Injection
Drug company
• Heron Therapeutics
Indication
• To prevent chemotherapy-induced nausea and vomiting, in combination with other drugs
Patient support services
• Heron Connect Copay Assistance Program
  844-437-6611
  
  Heron Connect Patient Assistance Program
  844-437-6611
  
  Heron Commitment Program
  844-437-6611

Drug name (generic name)
• Varubi (rolapitant) Tablets
Drug company
• TerSera Therapeutics
Indication
• To prevent chemotherapy-induced nausea and vomiting, in combination with other antiemetic drugs
Patient support services
• Varubi Co-Pay Card
  844-864-3014
  
  Reimbursement Hub
  
  Patient Assistance Program

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Actemra (tocilizumab)
Drug company
• Genentech
Indication
• Treatment of cytokine-release syndrome caused by CAR T-cell therapy
Patient support services
• Actemra Co-pay Card Program
  855-722-6729
  
  Genentech Patient Foundation
  888-941-3331

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Imbruvica (ibrutinib) Capsules/Tablets
Drug company
• Pharmacyclics
Indication
• Treatment of patients with GVHD, after failure of 1 or more systemic therapies
Patient support services
• Imbruvica By Your Side Program
  888-968-7743
  
  Johnson & Johnson Patient Assistance Foundation
  800-652-6227

Drug name (generic name)
• Jakafi (ruxolitinib) Tablets
Drug company
• Incyte
Indication
• Treatment of steroid-refractory acute GVHD, in patients aged 12 or older
  
  Treatment of chronic GVHD in patients aged 12 years or older who have received 1 or 2 previous lines of systemic therapy
Patient support services
• IncyteCARES Jakafi Savings Program
  855-452-5234
  
  IncyteCARES Jakafi Patient Assistance Program
  855-452-5234
  
  IncyteCARES Jakafi Temporary Access Program
  855-452-5234

Drug name (generic name)
• Orencia (abatacept)
Drug company
• Bristol Myers Squibb
Indication
• Treatment of adults and pediatric patients 2 years of age and older undergoing hematopoietic stemcell transplantation from a matched or 1 allele-mismatched unrelated donor
Patient support services
• ORENCIA On Call
  800-673-6242

Drug name (generic name)
• Rezurock (belumosudil) Tablets
Drug company
• Kadmon Pharmaceuticals
Indication
• Treatment of patients aged 12 years or older with chronic GVHD who have received at least 2 previous lines of systemic therapy
Patient support services
• Kadmon ASSIST Commercial Co-pay Savings Program
  844-523-6661
  
  Kadmon ASSIST Patient Assistance Program
  844-523-6661
  
  QuickStart Program
  844-523-6661
  
  Bridge Program
  844-523-6661

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Fulphila (pegfilgrastim-jmdb) Injection
Drug company
• Mylan
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
Patient support services
• Viatris Advocate Co-Pay Assistance Program
  833-695-2623
  
  Viatris Advocate Patient Assistance Program
  833-695-2623

Drug name (generic name)
• Neulasta (pegfilgrastim) Injection
Drug company
• Amgen
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
Patient support services
• Amgen FIRST STEP Co-Pay Program
  866-264-2778
  
  Amgen Safety Net Foundation
  866-264-2778

Drug name (generic name)
• Neupogen (filgrastim) Injection
Drug company
• Amgen
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
  
  Treatment of neutropenia
Patient support services
• Amgen FIRST STEP Co-Pay Program
  866-264-2778
  
  Amgen Safety Net Foundation
  866-264-2778

Drug name (generic name)
• Nivestym (filgrastim-aafi) Injection
Drug company
• Pfizer
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
Patient support services
• Pfizer Oncology Together Co-Pay Assistance Program
  877-744-5675
  
  Pfizer Patient Assistance Program
  877-744-5675

Drug name (generic name)
• Udenyca (pegfilgrastim-cbqv) Injection
Drug company
• Coherus BioSciences
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
Patient support services
• Coherus COMPLETE Co-Pay Assistance Program
  844-483-3692
  
  Coherus COMPLETE Patient Assistance Program
  844-483-3692

Drug name (generic name)
• Zarxio (filgrastim-sndz) Injection
Drug company
• Sandoz
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
  
  Treatment of neutropenia
Patient support services
• Sandoz One Source Commercial Co-Pay Program
  844-726-3691

Drug name (generic name)
• Ziextenzo (pegfilgrastim-bmez) Injection
Drug company
• Sandoz
Indication
• To prevent febrile neutropenia associated with myelosuppressive chemotherapy
Patient support services
• Sandoz One Source Commercial Co-Pay Program
  844-726-3691